PHILADELPHIA–(BUSINESS WIRE)–Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has completed the previously announced sale of its Elixir Solutions business (“Elixir”) to MedImpact Healthcare Systems, Inc. (“MedImpact”) for approximately $576.5 million. “We are pleased to finalize the sale of Elixir, marking another important milestone in our transformation to strengthen our long-term financial position,” said Jeffrey S. Stein, Rite Aid’s CEO and Chief Restruct
Business Wire Merger/Acquisition News
